ASSOCIATIONS BETWEEN N-TERMINAL PROCOLLAGEN TYPE III (PIIINP) AND VENTRICULAR REMODELLING IN DOGS WITH MITRAL VALVE DISEASE
Presentation / Conference Contribution
Hezzell, M. J., Boswood, A., & Elliott, J. ASSOCIATIONS BETWEEN N-TERMINAL PROCOLLAGEN TYPE III (PIIINP) AND VENTRICULAR REMODELLING IN DOGS WITH MITRAL VALVE DISEASE
All Outputs (56)
TOLERANCE OF SPIRONOLACTONE IN HEALTHY BEAGLE DOGS
Presentation / Conference Contribution
Elliott, J., Coussanes, E., & Guyonnet, J. TOLERANCE OF SPIRONOLACTONE IN HEALTHY BEAGLE DOGS
IMMUNOHISTOCHEMICAL EXPRESSION OF CYCLOOXYGENASE (COX)-1 AND-2 ENZYMES IN FELINE CHRONIC KIDNEY DISEASE
Presentation / Conference Contribution
Suemanotham, N., Syme, H. M., Berhane, Y., Smith, K. C., & Elliott, J. IMMUNOHISTOCHEMICAL EXPRESSION OF CYCLOOXYGENASE (COX)-1 AND-2 ENZYMES IN FELINE CHRONIC KIDNEY DISEASE
EFFECT OF TELMISARTAN ON ANGIOTENSIN II-INDUCED CONTRACTION OF FELINE ARTERIES
Presentation / Conference Contribution
Berhane, Y., Sent, U., & Elliott, J. EFFECT OF TELMISARTAN ON ANGIOTENSIN II-INDUCED CONTRACTION OF FELINE ARTERIES
AMINE METABOLISM BY SEMICARBAZIDE-SENSITIVE AMINE OXIDASE MODULATES ENDOTHELIAL CELL FUNCTION OF EQUINE DIGITAL VESSELS
Presentation / Conference Contribution
Berhane, Y., Putignano, C., Morris, G., Zerpa, H., Crawford, C., Harris, P., & Elliott, J. AMINE METABOLISM BY SEMICARBAZIDE-SENSITIVE AMINE OXIDASE MODULATES ENDOTHELIAL CELL FUNCTION OF EQUINE DIGITAL VESSELS
IATROGENIC HYPOTHYROIDISM (IH) CONTRIBUTES TO THE DEVELOPMENT OF AZOTEMIA IN HYPERTHYROID CATS
Presentation / Conference Contribution
Williams, T. L., Elliott, J., & Syme, H. M. IATROGENIC HYPOTHYROIDISM (IH) CONTRIBUTES TO THE DEVELOPMENT OF AZOTEMIA IN HYPERTHYROID CATS
MANAGEMENT OF FELINE CHRONIC KIDNEY DISEASE - CLINICAL PHARMACOLOGY AND THERAPEUTICS
Presentation / Conference Contribution
Elliott, J. MANAGEMENT OF FELINE CHRONIC KIDNEY DISEASE - CLINICAL PHARMACOLOGY AND THERAPEUTICS
MODULATION OF ENDOTHELIUM-DEPENDENT RELAXATION OF EQUINE DIGITAL ARTERIES BY INSULIN AND HYPOXIA
Presentation / Conference Contribution
Berhane, Y., Jordan, H., Bailey, S. R., Zerpa, H., Borer, K. E., Menzies-Gow, N. J., Harris, P. A., & Elliott, J. MODULATION OF ENDOTHELIUM-DEPENDENT RELAXATION OF EQUINE DIGITAL ARTERIES BY INSULIN AND HYPOXIA
CHANGES IN PLASMA FIBROBLAST GROWTH FACTOR-23 (FGF-23) CONCENTRATIONS AFTER TREATMENT OF HYPERTHYROIDISM (HTH) IN CATS WITH VARIABLE RENAL FUNCTION
Presentation / Conference Contribution
Williams, T. L., Elliott, J., & Syme, H. M. CHANGES IN PLASMA FIBROBLAST GROWTH FACTOR-23 (FGF-23) CONCENTRATIONS AFTER TREATMENT OF HYPERTHYROIDISM (HTH) IN CATS WITH VARIABLE RENAL FUNCTION
USE OF SURFACE ENHANCED LASER DESORPTION IONIZATION TIME-OF-FLIGHT MASS SPECTROMETRY (SELDI-TOF-MS) AS A URINARY BIOMARKER DISCOVERY TOOL IN CATS AT RISK OF DEVELOPING AZOTEMIA
Presentation / Conference Contribution
Jepson, R. E., Syme, H. M., & Elliott, J. USE OF SURFACE ENHANCED LASER DESORPTION IONIZATION TIME-OF-FLIGHT MASS SPECTROMETRY (SELDI-TOF-MS) AS A URINARY BIOMARKER DISCOVERY TOOL IN CATS AT RISK OF DEVELOPING AZOTEMIA
SEASONAL INFLUENCE ON INSULIN AND CORTISOL RESULTS FROM OVERNIGHT DEXAMETHASONE SUPPRESSION TESTS (DST) IN NORMAL AND PREVIOUSLY LAMINITIC PONIES
Presentation / Conference Contribution
Borer, K. E., Menzies-Gow, N. J., Berhane, Y., Bailey, S. R., Harris, P. A., & Elliott, J. SEASONAL INFLUENCE ON INSULIN AND CORTISOL RESULTS FROM OVERNIGHT DEXAMETHASONE SUPPRESSION TESTS (DST) IN NORMAL AND PREVIOUSLY LAMINITIC PONIES
FIBROBLAST GROWTH FACTOR 23 (FGF-23) IN FELINE CHRONIC KIDNEY DISEASE
Presentation / Conference Contribution
Geddes, R. F., Finch, N. C., Elliott, J., & Syme, H. M. FIBROBLAST GROWTH FACTOR 23 (FGF-23) IN FELINE CHRONIC KIDNEY DISEASE
FGF-23-MEDIATOR OF RENAL SECONDARY HYPERPARATHYROIDISM OR A MARKER OF GLOMERULAR FILTRATION RATE (GFR) IN CATS?
Presentation / Conference Contribution
Finch, N. C., Geddes, R. F., Syme, H. M., & Elliott, J. FGF-23-MEDIATOR OF RENAL SECONDARY HYPERPARATHYROIDISM OR A MARKER OF GLOMERULAR FILTRATION RATE (GFR) IN CATS?
URINARY VASCULAR ENDOTHELIAL GROWTH FACTOR AS A MARKER OF RENAL HYPOXIA IN CATS
Presentation / Conference Contribution
Chakrabarti, S., Syme, H. M., & Elliott, J. URINARY VASCULAR ENDOTHELIAL GROWTH FACTOR AS A MARKER OF RENAL HYPOXIA IN CATS
RESTORATION OF EUTHYROIDISM IN MEDICALLY TREATED HYPERTHYROID CATS WITH IATROGENIC HYPOTHYROIDISM (IH) IMPROVES RENAL FUNCTION
Presentation / Conference Contribution
Williams, T. L., Elliott, J., & Syme, H. M. RESTORATION OF EUTHYROIDISM IN MEDICALLY TREATED HYPERTHYROID CATS WITH IATROGENIC HYPOTHYROIDISM (IH) IMPROVES RENAL FUNCTION
PHARMACOKINETICS AND PHARMACOKINETIC/PHARMACODYNAMIC MODELLING OF ROBENACOXIB AND KETOPROFEN IN A CARRAGEENAN-INDUCED INFLAMMATION MODEL IN THE CAT
Presentation / Conference Contribution
Pelligand, L., King, J. N., Hormazabal, V., Toutain, P. L., Elliott, J., & Lees, P. PHARMACOKINETICS AND PHARMACOKINETIC/PHARMACODYNAMIC MODELLING OF ROBENACOXIB AND KETOPROFEN IN A CARRAGEENAN-INDUCED INFLAMMATION MODEL IN THE CAT
CISPLATIN-INDUCED EMESIS IN DOGS: EVALUATION OF ARGININE VASOPRESSIN AND CORTISOL AS BIOMARKERS OF NAUSEA
Presentation / Conference Contribution
Kenward, H., Pelligand, L., Tattersall, F. D., Savary-Bataille, K., & Elliott, J. CISPLATIN-INDUCED EMESIS IN DOGS: EVALUATION OF ARGININE VASOPRESSIN AND CORTISOL AS BIOMARKERS OF NAUSEA
ASSOCIATIONS BETWEEN N-TERMINAL PROCOLLAGEN TYPE III (PIIINP), FIBROSIS AND ECHOCARDIOGRAPHIC INDICES IN DOGS WITH MITRAL VALVE DISEASE
Presentation / Conference Contribution
Hezzell, M. J., Falk, T., Olsen, L. H., Boswood, A., & Elliott, J. ASSOCIATIONS BETWEEN N-TERMINAL PROCOLLAGEN TYPE III (PIIINP), FIBROSIS AND ECHOCARDIOGRAPHIC INDICES IN DOGS WITH MITRAL VALVE DISEASE
FEEDING A RENAL DIET IS ASSOCIATED WITH A REDUCTION IN PLASMA FIBROBLAST GROWTH FACTOR 23 (FGF-23) IN CATS WITH STABLE CHRONIC KIDNEY DISEASE (CKD)
Presentation / Conference Contribution
Geddes, R. F., Elliott, J., & Syme, H. M. FEEDING A RENAL DIET IS ASSOCIATED WITH A REDUCTION IN PLASMA FIBROBLAST GROWTH FACTOR 23 (FGF-23) IN CATS WITH STABLE CHRONIC KIDNEY DISEASE (CKD)
RATIONALE OF A COMBINATION OF SPIRONOLACTONE AND BENAZEPRIL FOR TREATMENT OF HEART FAILURE IN DOG
Presentation / Conference Contribution
Elliott, J., Geneteau, A., Guyonnet, J., & Kaltsatos, V. RATIONALE OF A COMBINATION OF SPIRONOLACTONE AND BENAZEPRIL FOR TREATMENT OF HEART FAILURE IN DOG